Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to EUR 6.2 billion, 23.2% of group net salesCompany prepares ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Company Logo Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1 ...

Therefore, dive into a visual journey through time with us, and witness the evolution of the GTA logo: from pixelated GTA 1 origins to sleek, neon-soaked GTA 6 logo. The first logo from the iconic ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Promote your business through our innovative Marketplace system! It's free to sign up!